Amyloid Deposits and Amyloidosis: The β-Fibrilloses

New England Journal of Medicine

Volumn 302, Issue 24, 1980, Pages 1333-1343

  Glenner, George G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; DIMETHYL SULFOXIDE;

AMYLOIDOSIS; DIAGNOSIS; DRUG THERAPY; ETIOLOGY; HEART; KIDNEY; PATHOGENESIS; REVIEW; THERAPY;

ADRENAL CORTEX HORMONES; AGED; AMYLOID; AMYLOIDOSIS; ANTINEOPLASTIC AGENTS; BENCE JONES PROTEIN; BIOPSY; BRAIN DISEASES; CHILD; COLCHICINE; DIMETHYL SULFOXIDE; FEMALE; HUMAN; IMMUNOGLOBULINS; KIDNEY DISEASES; MALE; MIDDLE AGE; MULTIPLE MYELOMA; MYOCARDIAL DISEASES; SKIN DISEASES;

EID: 0018868515     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198006123022403     Document Type: Review

References (110)

1. Snapper I., Kahn A. Myelomatosis: fundamentals and clinical features. Baltimore: University Park Press, 1971: 380.
2. Pruzanski W., Hasselback R., Katz A., Parr D.M. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and μ-heavy chain fragment in the serum. Am J Med. 1978; 65:334-341.
3. Pick A.I., Versano 1, Schreibman S., Ben-Bassat M., Shoenfeld Y. Agammaglobulinemia, plasma cell dyscrasia, and amyloidosis in a 12-year-old child. Am J Dis Child. 1977; 131:682-686.
4. Knowles D.M. II, Shevchuk M. Pleomorphic reticulum cell sarcoma, monoclonal gammopathy and amyloidosis: an immunoperoxidase study. Cancer. 1978; 41:1883-1889.
5. Benditt E.P., Eriksen N. Chemical similarity among amyloid substances associated with long standing inflammation. Lab Invest. 1972; 26:615-625.
6. Tripathi V.N.P., Desautels R.E. Primary amyloidosis of the urogenital system: a study of 16 cases and brief review. J Urol. 1969; 102:96-101.
7. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore). 1976; 55:217-238.
8. Glass R., Scheie H.G., Yanoff M. Conjunctival amyloidosis arising from a plasmacytoma. Ann Ophthalmol. 1971; 3:823-825.
9. Friman C., Törnroth T., Wegelius O. IgD myeloma associated with multiple extramedullary amyloid-containing tumours and amyloid casts in the renal tubules. Ann Clin Res. 1970; 2:161-166.
10. David R., Buchner A. Amyloid stroma in a tubular carcinoma of palatal salivary gland: a histochemical and ultrastructural study. Cancer. 1978; 41:1836-1844.
11. Schrodt G.R., Murray M. The keratin structure of corpora amylacea. Arch Pathol. 1966; 82:518-525.
12. Wright J.R., Calkins E., Breen W.J., Stolte G., Schultz R.T. Relationship of amyloid to aging: review of the literature and systematic study of 83 patients derived from a general hospital population. Medicine (Baltimore). 1969; 48:39-60.
13. Osserman E.F. Amyloidosis and plasma cell dyscrasia. In: Grabar P, Miescher PA, eds. Immunopathology: IVth International Symposium. New York: Grune & Stratton, 1965: 283-93.
14. Kyle R.A., Bayrd E.D. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975; 54:271-299.
15. Pruzanski W., Katz A. Clinical and laboratory findings in primary generalized and multiple-myeloma-related amyloidosis. Can Med Assoc J. 1976; 114:906-909.
16. Benson M.D., Cohen A.S., Brandt K.D., Cathcart E.S. Neuropathy, M components, and amyloid. Lancet. 1975; 1:10-12.
17. Trotter J.L., Engel W.K., Ignaczak T.F. Amyloidosis with plasma cell dyscrasia: an overlooked cause of adult onset sensorimotor neuropathy. Arch Neurol. 1977; 34:209-214.
18. Buja L.M., Khoi N.B., Roberts W.C. Clinically significant cardiac amyloidosis: clinicopathologic findings in 15 patients. Am J Cardiol. 1970; 26:394-405.
19. Rubinow A., Celli B.R., Cohen A.S., Rigden B.G., Brody J.S. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis. 1978; 118:603-613.
20. Goltz R.W. Systematized amyloidosis: a review of the skin and mucous membrane lesions and a report of two cases. Medicine (Baltimore). 1952; 31:381-409.
21. Katz G.A., Peter J.B., Pearson C.M., Adams W.S. The shoulder-pad sign — a diagnostic feature of amyloid arthropathy. N Engl J Med. 1973; 288:354-355.
22. Furie B., Greene E., Furie B.C. Syndrome of acquired factor X deficiency and systemic amyloidosis: in vivo studies of the metabolic fate of factor X. N Engl J Med. 1977; 297:81-85.
23. Bastian F.O. Amyloidosis and the carpal tunnel syndrome. Am J Clin Pathol. 1974; 61:711-717.
24. Shustik C., Bergsagel D.E., Pruzanski W. κ and λ light chain disease: survival rates and clinical manifestations. Blood. 1976; 48:41-51.
25. McCallister B.D., Bayrd E.D., Harrison E.G. Jr., McGuckin W.F. Primary macroglobulinemia: review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am J Med. 1967; 43:394-434.
26. Cohen R.J., Bohannon R.A., Wallerstein R.O. Waldenström#x0027;s macroglobulinemia: a study of ten cases. Am J Med. 1966; 41:274-284.
27. Forget B.G., Squires J.W., Sheldon H. Waldenström#x0027;s macroglobulinemia with generalized amyloidosis. Arch Intern Med. 1966; 118:363-378.
28. Terashima K., Takahashi K., Kojima M., Oonuma H., Tsuchida H., Kikuchi T. An autopsy case of systemic primary amyloidosis associated with γ-M pyroglobulinemia. J Reticuloendothel Soc. 1971; 10:373-391.
29. Coppola A., Yermakov V., Caggiano V. Pleomorphic lymphoma and gastric adenocarcinoma (collision neoplasm) associated with monoclonal macroglobulinemia and amyloidosis: a case report. Cancer. 1969; 23:576-585.
30. Franklin E.C. μ-Chain disease. Arch Intern Med. 1975; 135:71-72.
31. Frangione B., Franklin E.C. Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure. Semin Hematol. 1973; 10:53-64.
32. Osserman E.F., Takatsuki K. Clinical and immunochemical studies of four cases of heavy chain (Hγ2) chain disease. Am J Med. 1964; 37:351-373.
33. Pruzanski W., Katz A., Nyburg S.C., Freedman M.H. In vitro production of an amyloid-like substance from γ3 heavy chain disease protein. Immunol Commun. 1974; 3:469-476.
34. Tschang T.-P. Nodular malignant lymphoma and amyloidosis: a case report. Cancer. 1976; 38:2192-2196.
35. Madri J.A., Fromowitz F. Amyloid deposition in immunoblastic lymphadenopathy. Hum Pathol. 1978; 9:157-162.
36. Christensen H.E., Rask-Nielsen R. Comparative morphologic, histochemical, and serologic studies on the pathogenesis of casein-induced and reticulosarcoma-induced amyloidosis in mice. J Natl Cancer Inst. 1962; 28:1-34.
37. Husby G. Amyloidosis in rheumatoid arthritis. Ann Clin Res. 1975; 7:154-167.
38. Missen G.A.K., Taylor J.D. Amyloidosis in rheumatoid arthritis. J Pathol Bacteriol. 1956; 71:179-192.
39. Ozdemir A.I., Wright J.R., Calkins E. Influence of rheumatoid arthritis on amyloidosis of aging: comparison of 47 rheumatoid patients with 47 controls matched for age and sex. N Engl J Med. 1971; 285:534-538.
40. Westermark P., Sletten K., Ericksson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab Invest. 1979; 41:427-431.
41. Smith M.E., Ansell B.M., Bywaters E.G.L. Mortality and prognosis related to the amyloidosis of Still#x0027;s disease. Ann Rheum Dis. 1968; 27:137-145.
42. Schnitzer T.J., Ansell B.M. Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum. 1977; 20: Suppl:245-252.
43. Kennedy AC, Burton J.A., Allison M.E.M. Tuberculosis as a continuing cause of renal amyloidosis. Br Med J. 1974; 3:795-797.
44. Williams R.C. Jr., Cathcart E.S., Calkins E., Fite G.L., Rubio J.B., Cohen A.S. Secondary amyloidosis in lepromatous leprosy: possible relationship of diet and environment. Ann Intern Med. 1965; 62:1000-1007.
45. Somer T., Teppo L. Hypernephroma and amyloidosis. In: Wegelius O, Pasternack A, eds. Amyloidosis. New York: Academic Press, 1976: 455-70.
46. Hashimoto K., Gross B.G., Lever W.F. Lichen amyloidosus: histochemical and electron microscopic studies. J Invest Dermatol. 1965; 45:204-219.
47. Brownstein M.H., Helwig E.B. The cutaneous amyloidoses. I. Localized forms. Arch Dermatol. 1970; 102:8-19.
48. Hashimoto K., Kumakiri M. Colloid-amyloid bodies in PUVA-treated human psoriatic patients. J Invest Dermatol. 1979; 72:70-80.
49. Hashimoto K. Apoptosis in lichen planus and several other dermatoses: intra-epidermal cell death with filamentous degeneration. Acta Derm Venereol (Stockh). 1976; 56:187-210.
50. Divry P. De la nature de l#x0027;altération fibrillaire d#x0027;Alzheimer. J Belge Neurol Psychiatr. 1934; 34:197-201.
51. Scholz W. Studien zur pathologic der Hirngefässe. II. Die drüsige Entartung der Hirnarterien und -capillaren. Z Ges Neurol Psychiatr. 1938; 162:694-715.
52. Morel F., Wildi E. General and cellular pathochemistry of senile and presenile alterations of the brain. In: Atti del primo Congrèsso internazionale di Istopatologia del Sistèma nervoso. Turin: Casa Editrice Libraria, 1952: 347-74.
53. Wiśniewski H.M., Terry R.D. Reexamination of the pathogenesis of the senile plaque. In: Zimmerman HM, ed. Progress in neuropathology, Vol. 2. New York: Grune & Stratton, 1973: 1-26.
54. Kidd M. Paired helical filaments in electron microscopy of Alzheimer#x0027;s disease. Nature. 1963; 197:192-193.
55. Wiśniewski H., Terry R.D., Hirano A. Neurofibrillary pathology. J Neuropathol Exp Neurol. 1970; 29:163-176.
56. Burger P.C., Vogel F.S. The development of the pathologic changes of Alzheimer#x0027;s disease and senile dementia in patients with Down#x0027;s syndrome. Am J Pathol. 1973; 73:457-476.
57. Kidd M. Alzheimer#x0027;s disease — an electron microscopical study. Brain. 1964; 87:307-327.
58. Mandybur T.I., Nagpaul A.S., Pappas Z., Niklowitz W.J. Alzheimer neurofibrillary change in subacute sclerosing panencephalitis. Ann Neurol. 1977; 1:103-107.
59. Wiśniewski H., Shelanski M.L., Terry R.D. Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells. J Cell Biol. 1968; 38:224-229.
60. Tellez-Nagel I., Wiśniewski H.M. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol. 1973; 29:324-327.
61. Chou S.M., Martin J.D. Kuru-plaques in a case of Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 1971; 17:150-155.
62. Surbeck E.B. L#x0027;angiopathie dyshorique (Morel) de l#x0027;ecorce cerebrale: étude anatomoclinique et statistique: aspect genetique. (Thesis). Geneva, 1961.
63. Heffner R.R., Porro R.S., Olson M.E., Earle K.M. A demyelinating disorder associated with cerebrovascular amyloid angiopathy. Arch Neurol. 1976; 33:501-506.
64. Jellinger K. Zur Ätiologie und Pathogenese der spontanen intrazerebralen Blutung. Therapiewoche. 1972; 22:1440-1450.
65. Mandybur T.I., Bates S.R.D. Fatal massive intracerebral hemorrhage complicating cerebral amyloid angiopathy. Arch Neurol. 1978; 35:246-248.
66. Glenner G.G. Congophilic microangiopathy in the pathogenesis of Alzheimer#x0027;s syndrome. Med Hypoth. 1979; 5:1231-1236.
67. Buerger L., Braunstein H. Senile cardiac amyloidosis. Am J Med. 1960; 28:357-367.
68. Ridolfi R.L., Bulkley B.H., Hutchins G.M. The conduction system in cardiac amyloidosis: clinical and pathologic features of 23 patients. Am J Med. 1977; 62:677-686.
69. Battaglia S., Trentini G.P. Aortic amyloidosis in adult life. Virchows Arch [Pathol Anat]. 1978; 378:153-161.
70. Iwata T., Kamei T., Uchino F., Mimaya H., Yanagaki T., Etoh H. Pathological study on amyloidosis — relationship of amyloid deposits in the aorta to aging. Acta Pathol Jpn. 1978; 28:193-203.
71. Wright J.R., Calkins E. Relationship of amyloid deposits in the human aorta to aortic atherosclerosis: a postmortem study of 100 individuals over 60 years of age. Lab Invest. 1974; 30:767-773.
72. Ravid M., Gafni J., Sohar E., Missmahl H.-P. Incidence and origin of nonsystemic microdeposits of amyloid. J Clin Pathol. 1967; 20:15-20.
73. Azar H.A. Amyloidoses and plasma cell disorders. In: Azar HA, Potter M, eds. Multiple myeloma and related disorders. Vol. 1. New York: Harper & Row, 1973: 328-403.
74. Dyke P.C., Demaray M.J., Delavan J.W., Rasmussen R.A. Pulmonary amyloidoma. Am J Clin Pathol. 1974; 61:301-305.
75. Fenoglio C., Pascal R.R. Nodular amyloidosis of the lungs: an unusual case associated with chronic lung disease and carcinoma of the bladder. Arch Pathol. 1970; 90:577-582.
76. Alroy C.G., Lichtig C., Kaftori J.K. Tracheobronchopathia osteoplastica: end stage of primary lung amyloidosis? Chest. 1972; 61:465-468.
77. Demmler K. Amyloidzylinder der Nieren bei Plasmozytom. Blut. 1969; 18:343-347.
78. Abrahams C., Pirani C.L., Pollak V.E. Ultrastructure of the kidney in a patient with multiple myeloma. J Pathol Bacteriol. 1966; 92:220-225.
79. Koss M.N., Pirani C.L., Osserman E.F. Experimental Bence Jones cast nephropathy. Lab Invest. 1976; 34:579-591.
80. Michaels L., Levene C. Pulmonary corpora amylacea. J Pathol Bacteriol. 1957; 74:49-56.
81. Livni N., Behar A.J., Lafair J.S. Unusual amyloid bodies in human liver: ultrastructural and freeze-etching studies. Isr J Med Sci. 1977; 13:1163-1170.
82. Beems R.B., Gruys E., Spit B.J. Amyloid in the corpora amylacea of the rat mammary gland. Vet Pathol. 1978; 15:347-352.
83. Gueft B. The x-ray diffraction pattern of prostatic corpora amylacea. Acta Pathol Microbiol Scand [A], 1972; 80: Suppl 233:132-134.
84. McAdam K.P.W.J., Elin R.J., Sipe J.D., Wolff S.M. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest. 1978; 61:390-394.
85. Sipe J.D., McAdam K.P.W.J., Uchino F. Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest. 1978; 38:110-114.
86. Benson M.D., Scheinberg M.A., Shirahama T., Cathcart E.S., Skinner M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest. 1977; 59:412-417.
87. Cooke R.A., Champness L.T. Amyloidosis in Papua-New Guinea. Med J Aust. 1970; 2:1177-1184.
88. Derosena R., Koss M.N., Pirani C.L. Demonstration of amyloid fibrils in urinary sediment. N Engl J Med. 1975; 293:1131-1133.
89. Nimoityn P., Lasker N., Soriano R.Z. Detection of urinary amyloid in familial Mediterranean fever. Br Med J. 1976; 2:284.
90. Shirahama T., Skinner M., Cohen A.S., Benson M.D. Uncertain value of urinary sediments in the diagnosis of amyloidosis. N Engl J Med. 1977; 297:821-823.
91. Orfila C., de Graeve P., Guilhem A., Suc J.M. Study of light-, electron-and immunofluorescence microscopy of urinary sediment in amyloidosis. Virchows Arch [Pathol Anat]. 1978; 379:113-118.
92. Gordon D.A., Pruzanski W., Ogryzlo M. Synovial fluid examination for the diagnosis of amyloidosis. Ann Rheum Dis. 1973; 32:428-430.
93. Cohen A.S., Canoso J.J. Rheumatological aspects of amyloid disease. Clin Rheum Dis. 1975; 1:149-161.
94. Gafni J., Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci. 1960; 240:332-336.
95. Stenkvist B., Westermark P., Wibell L. Simple method of diagnostic screening for amyloidosis. Ann Rheum Dis. 1974; 33:75-76.
96. DeLellis R.L., Bowling M.C. The use of Sirius red and Congo red staining in routine histopathology. Hum Pathol. 1970; 1:655.
97. Wright J.R., Humphrey R.L., Calkins E. Different molecular forms of amyloid histologically distinguished by susceptibility or resistance to trypsin digestion. In: Wegelius O, Pasternack A, eds. Amyloidosis. New York: Academic Press, 1976: 51-9.
98. Cornwell G.G. III, Husby G., Westermark P., Natvig J.B., Michaelsen T.E., Skogen B. Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol. 1977; 6:1071-1080.
99. Schultz R.T. Role of altered vascular permeability in amyloid formation. Am J Pathol. 1977; 86:321-342.
100. Barth W.F., Willerson J.D., Waldmann T.A., Decker J.L. Primary amyloidosis: clinical, immunochemical and immunoglobulin metabolism studies in fifteen patients. Am J Med. 1969; 47:259-273.
101. Dikman S.H., Kahn T., Gribetz D., Churg J. Resolution of renal amyloidosis. Am J Med. 1977; 63:430-433.
102. Cohen H.J. Combination chemotherapy for primary amyloidosis reconsidered. Ann Intern Med. 1978; 89:572.
103. Falck H., Skrifvars B., Wegelius O. Treatment of amyloidosis secondary to rheumatoid arthritis with cyclophosphamide. In: Glenner GG, Costa PP, Freitas F, eds. Amyloid and amyloidosis. Amsterdam: Excerpta Medica, (in press).
104. Isobe T., Osserman E.F. Effects of dimethyl sulfoxide (DMSO) on Bence Jones proteins, amyloid fibrils and casein-induced amyloidosis. In: Wegelius O, Pasternack A, eds. Amyloidosis. New York: Academic Press, 1976: 247-57.
105. Kedar I., Greenwald M., Ravid M. Treatment of experimental murine amyloidosis with dimethyl sulfoxide. Eur J Clin Invest. 1977; 7:149-150.
106. van Rijswijk M., Ruinen L., Donker A., et al. Successful treatment with dimethyl sulfoxide of human amyloidosis secondary to rheumatoid arthritis. In: Glenner GG, Costa PP, Freitas F, eds. Amyloid and amyloidosis. Amsterdam: Excerpta Medica, (in press).
107. Osserman E.F., Sherman W.H., Kyle A. Further studies of therapy of amyloidosis with dimethyl sulfoxide (DMSO). In: Glenner GG, Costa PP, Freitas F, eds. Amyloid and amyloidosis. Amsterdam: Excerpta Medica, (in press).
108. Greipp P.R., Kyle R.A., Bowie E.J.W. Factor X deficiency in primary amyloidosis: resolution after splenectomy. N Engl J Med. 1979; 301:1050-1051.
109. Ben Ari J., Zlotnik M., Oren A., Berlyne G.M. Dialysis in renal failure caused by amyloidosis of familial Mediterranean fever: a report of ten cases. Arch Intern Med. 1976; 136:449-451.
110. Benson M.D., Skinner M., Cohen A.S. Amyloid deposition in a renal transplant in familial Mediterranean fever. Ann Intern Med. 1977; 87:31-34.